Financial year from 01-01-2026 to 24-04-2026, 4 monthsDissolution with immediate closure of the liquidation13-05Dividend €14,215Equity from €80,102 to €68,024Debts from €9,511 to €18,822Cash from €42,087 to €90
Key points
from the 2026 annual accounts, the last ones filed
Dissolution with immediate closure of the liquidation
Dissolved and wound up in a single deed · Books and records kept in Aalst · Name after signing inVisible after signing in appointed as statutory auditor · Gazette deed
Amendment of the articles · Legal-form change · Resignations & appointmentsName hiddenVisible after signing in resigns as manager · Hidden nameVisible after signing in reappointed as director · Name after signing inVisible after signing in holds all the shares · General meeting of 30-11-2023 · Gazette deed
IncorporationName hiddenVisible after signing in appointed as manager · Founded by Hidden nameVisible after signing in · Founded by Name after signing inVisible after signing in · published on 05-03-2018 · Gazette deed
Dissolved and wound up in a single deed on 13-05-2026. The last annual accounts are for financial year 2026. The company was dissolved and wound up in a single deed. The books and records are kept in Aalst.
The company number of ACOCURA is 0691.635.239. The VAT number is the same number with BE in front: BE 0691.635.239.
What is the legal form of ACOCURA?
ACOCURA is a private limited company (BV).
Is ACOCURA still active?
No. Dissolved and wound up in a single deed on 13-05-2026. The company has been out of the KBO register since 13-05-2026.Company details
What is the turnover of ACOCURA?
The turnover in financial year 2026 is about €87,000. This figure is estimated from the gross margin of €11,704 and 7,105 comparable companies of the same size. It probably lies between €40,000 and €210,000. It is a rough estimate.Financials
Is ACOCURA profitable?
In financial year 2026, ACOCURA made a profit of €2,137.
Where can I find the annual accounts of ACOCURA?
ACOCURA filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2026.